Inventor · disambiguated record
Matthew David Max Crispin
Also filed as: CRISPIN MATTHEW DAVID MAX
0 granted patents·5 pending applications·0 citations·filing 2007–2023
Top patents by PatentIndex Score
5 records- 0154US2023398212A1Combined therapeutic use of antibodies and immunoglobulin g-degrading enzymesHANSA BIOPHARMA LTD·Filed 2023·Application pending·0 cites
- 0241US2010022620A1Epitope reduction therapyCRISPIN MATTHEW DAVID MAX·Filed 2007·Application pending·0 cites
- 0340US2020345844A1Combined therapeutic use of antibodies and immunoglobulin g-degrading enzymesIMMAGO BIOSYSTEMS LTD·Filed 2020·Application pending·0 cites
- 0430US2015125443A1Combined therapeutic use of antibodies and endoglycosidasesCRISPIN RAYMOND JOHN·Filed 2013·Application pending·0 cites
- 0528US2017274070A1Combined therapeutic use of antibodies and endoglycosidasesIMMAGO BIOSYSTEMS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew David Max Crispin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →